Přejít k hlavnímu obsahu
Header image

Journals 2025

High-risk HPV prevalence in the Czech cervical cancer screening population: a comparison of clinician-collected and self-collected sampling. European Journal of Public Health. 2025, ISSN: 1101-1262, PMID: 40194781,  PDF.
ONDRAK FIALOVA, K., L. ONDRAK, M. VLK, J. KOZEMPEL, K. NOVAKOVA, Z. NOVÝ, K. HAJDUOVÁ, M. HAJDÚCH, M. PETŘÍK, M. PRUSZYNSKI, F. BRUCHERTSEIFER, A. MORGENSTERN
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 16, ISSN: 2365-421X, PMID: 40183827,  PDF.
ALLADI, C., R. RAJKUMAR, D. SHEWADE, L. GOENKA, S. SRINIVASMURTHY
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia. European Journal of Clinical Pharmacology. 2025, ISSN: 0031-6970, PMID: 40172663,  PDF.
CHRENKOVA, E., R. SPURNA, K. HOLA, J. VRBKOVÁ, J. KNILLOVÁ, M. LEVKOVÁ, H. ŠTUDENTOVÁ, J. BOUCHAL
Platelets, chromogranin A and C-reactive protein predict therapy failure of metastatic hormone-sensitive prostate cancer while miR-375 outperforms PSA in stratifying castration-resistant prostate cancer. The Journal of Molecular Diagnostics : JMD. 2025, S1525-1578(25), 00063-7, ISSN: 1525-1578, PMID: 40139458,
Novel C-2 Aromatic Heterocycle-Substituted Triterpenoids Inhibit Hedgehog Signaling in GLI1 Overexpression Cancer Cells. ACS Omega. 2025, 10(10), 10617-10632, ISSN: 2470-1343, PMID: 40124057,  PDF.
KRAL, M., D. KURFÜRSTOVÁ, P. ZEMLA, M. ELIÁŠ, J. BOUCHAL
New biomarkers and multiplex tests for diagnosis of aggressive prostate cancer and therapy management. Frontiers in Oncology. 2025, 15, 1542511, ISSN: 2234-943X , PMID: 40115018,  PDF.
Positron Emission Tomography Imaging of Acinetobacter baumannii Infection: Comparison of Gallium-68 Labeled Siderophores. ACS Infectious Diseases. 2025, ISSN: 2373-8227, PMID: 40099411,  PDF.
RAMPEESA, N., R. GUNDLA, G. MUDASANI, S. TANGALLAPALLI, S. ANUGU, S. GURSKÁ, J. DE SANCTIS, P. DŽUBÁK, M. HAJDÚCH, V. DAS
Identification of a novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activity. Bioorganic Chemistry. 2025, 157, 108316, ISSN: 0045-2068, PMID: 40037026,  PDF.
MUDSANI, G., N. RAMPEESA, S. ANUGU, P. MUDDASANI, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH
Design, synthesis, and biological evaluation of novel azaspirooxindolinone derivatives as potent inhibitors of ITK and BTK-dependent cancers. Bioorganic & Medicinal Chemistry. 2025, 121, 118116, ISSN: 0968-0896, PMID: 40015119,  PDF.
DUMUT, D., M. HAJDÚCH, A. ZACHARIAS, Q. DUAN, I. FRYDRYCH, Z. ROŽÁNKOVÁ, M. POPPER, D. GARIC, R. PAUN, A. CENTORAME, J. SHAH, M. MISTRÍK, P. DŽUBÁK, J. DE SANCTIS, D. RADZIOCH
Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis. Frontiers in Immunology. 2025, 16, 1491450, ISSN: 1664-3224 , PMID: 40013140,  PDF.